สำนักงานกฎหมายกราบาร์สอบสวนข้อกล่าวหาการละเมิดหน้าที่ fiduciary ต่อ ADMA Biologics, Commvault Systems, Erasca และ Hub Group

Investigation into fiduciary breaches, inadequate internal controls, channel-stuffing, and undisclosed related-party transactions.

Investigation into improper comparisons, undisclosed IP risks, patient death, and patent infringement allegations.

Investigation into allegedly misleading statements about annual recurring revenue growth guidance for fiscal year 2026.

Investigation into material misstatements due to premature revenue recognition and understated transportation costs.